Icon | Sustainability Performance
Contract research organization providing outsourced development and commercialization services
1990
Ireland
10,001+ employees
Biotechnology
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#37
Overallⓘ#2
in Irelandⓘ#1
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionSocial
Diversity and InclusionFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Critical
Controversy level
- ICON plc, Irish-headquartered global CRO (acquired PRA Health Sciences 2021 for USD 12 billion), has faced sustained US FDA Form 483 observations at multiple clinical trial sites and the contested historic Bracket/Endpoint Adjudication Service legacy quality compliance, plus periodic class actions over alleged inadequate disclosure of biotech customer concentration affecting institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.